Cargando…

Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats

Bile acids enhance colon carcinogenesis in animal models, whereas ursodeoxycholic acid (UDCA) suppresses it. Nonsteroid anti‐inflammatory drugs prevent colon cancer development in animals and humans. The aim of the present study was to explore the inhibitory effect of UDCA conjugate with 5‐aminosali...

Descripción completa

Detalles Bibliográficos
Autores principales: Narisawa, Tomio, Fukaura, Yoko, Takeba, Naomi, Nakai, Keiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926955/
https://www.ncbi.nlm.nih.gov/pubmed/11856477
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01252.x
_version_ 1783319000271290368
author Narisawa, Tomio
Fukaura, Yoko
Takeba, Naomi
Nakai, Keiko
author_facet Narisawa, Tomio
Fukaura, Yoko
Takeba, Naomi
Nakai, Keiko
author_sort Narisawa, Tomio
collection PubMed
description Bile acids enhance colon carcinogenesis in animal models, whereas ursodeoxycholic acid (UDCA) suppresses it. Nonsteroid anti‐inflammatory drugs prevent colon cancer development in animals and humans. The aim of the present study was to explore the inhibitory effect of UDCA conjugate with 5‐aminosalicylic acid (5‐ASA), UDCA‐5‐ASA conjugate (UDCA‐5‐ASA), against colon carcinogenesis in rats. One‐hundred‐and‐twenty‐nine 7‐week‐old F344 rats received an intrarectal instillation of 2 mg of N‐methylnitrosourea 3 tunes a week for 3 weeks, and were fed a 0% (control), 0.11% or 0.02% UDCA‐5‐ASA‐, 0.08% UDCA‐ or 0.03% 5‐ASA‐supplemented diet for the next 27 weeks. The test diets contained an equimolar amount of a test agent, 2.0 mmol/kg diet, except for the 0.02% UDCA‐5‐ASA diet. The tumor incidence and the mean number of tumors/rat at week 30 were significantly lower and smaller in the UDCA‐5‐ASA diet groups, 48% and 0.7 in both, and marginally lower in the UDCA and 5‐ASA diet groups, 56% and 0.9, and 64% and 0.8, compared to the control group, 83% and 1.3. All the tumors were polypoid in shape, and most of them were differentiated adenocarcinomas restricted to the mucosa or submucosa. An analysis by HPLC for bile acids and 5‐ASA in the feces and serum collected at week 30 showed that one‐half of ingested UDCA‐5‐ASA was cleaved into UDCA and 5‐ASA in the colon. Thus, the two moieties may have independently affected the promotion stage of carcinogenesis.
format Online
Article
Text
id pubmed-5926955
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59269552018-05-11 Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats Narisawa, Tomio Fukaura, Yoko Takeba, Naomi Nakai, Keiko Jpn J Cancer Res Article Bile acids enhance colon carcinogenesis in animal models, whereas ursodeoxycholic acid (UDCA) suppresses it. Nonsteroid anti‐inflammatory drugs prevent colon cancer development in animals and humans. The aim of the present study was to explore the inhibitory effect of UDCA conjugate with 5‐aminosalicylic acid (5‐ASA), UDCA‐5‐ASA conjugate (UDCA‐5‐ASA), against colon carcinogenesis in rats. One‐hundred‐and‐twenty‐nine 7‐week‐old F344 rats received an intrarectal instillation of 2 mg of N‐methylnitrosourea 3 tunes a week for 3 weeks, and were fed a 0% (control), 0.11% or 0.02% UDCA‐5‐ASA‐, 0.08% UDCA‐ or 0.03% 5‐ASA‐supplemented diet for the next 27 weeks. The test diets contained an equimolar amount of a test agent, 2.0 mmol/kg diet, except for the 0.02% UDCA‐5‐ASA diet. The tumor incidence and the mean number of tumors/rat at week 30 were significantly lower and smaller in the UDCA‐5‐ASA diet groups, 48% and 0.7 in both, and marginally lower in the UDCA and 5‐ASA diet groups, 56% and 0.9, and 64% and 0.8, compared to the control group, 83% and 1.3. All the tumors were polypoid in shape, and most of them were differentiated adenocarcinomas restricted to the mucosa or submucosa. An analysis by HPLC for bile acids and 5‐ASA in the feces and serum collected at week 30 showed that one‐half of ingested UDCA‐5‐ASA was cleaved into UDCA and 5‐ASA in the colon. Thus, the two moieties may have independently affected the promotion stage of carcinogenesis. Blackwell Publishing Ltd 2002-02 /pmc/articles/PMC5926955/ /pubmed/11856477 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01252.x Text en
spellingShingle Article
Narisawa, Tomio
Fukaura, Yoko
Takeba, Naomi
Nakai, Keiko
Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats
title Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats
title_full Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats
title_fullStr Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats
title_full_unstemmed Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats
title_short Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats
title_sort chemoprevention of n‐methylnitrosourea‐induced colon carcinogenesis by ursodeoxycholic acid‐5‐aminosalicylic acid conjugate in f344 rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926955/
https://www.ncbi.nlm.nih.gov/pubmed/11856477
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01252.x
work_keys_str_mv AT narisawatomio chemopreventionofnmethylnitrosoureainducedcoloncarcinogenesisbyursodeoxycholicacid5aminosalicylicacidconjugateinf344rats
AT fukaurayoko chemopreventionofnmethylnitrosoureainducedcoloncarcinogenesisbyursodeoxycholicacid5aminosalicylicacidconjugateinf344rats
AT takebanaomi chemopreventionofnmethylnitrosoureainducedcoloncarcinogenesisbyursodeoxycholicacid5aminosalicylicacidconjugateinf344rats
AT nakaikeiko chemopreventionofnmethylnitrosoureainducedcoloncarcinogenesisbyursodeoxycholicacid5aminosalicylicacidconjugateinf344rats